Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

2002 • 1,570 citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

2005 • 1,551 citations

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

1992 • 1,086 citations

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

2005 • 1,038 citations

Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality

2003 • 818 citations

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

1995 • 683 citations

Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles

1993 • 604 citations

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

1995 • 597 citations

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles

1991 • 511 citations

Efficient Intracellular Assembly of Papillomaviral Vectors

2003 • 468 citations

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

2006 • 453 citations

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

2006 • 452 citations

Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay

2003 • 281 citations

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

2005 • 271 citations

Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial

2005 • 259 citations

Surface Conformational and Linear Epitopes on HPV-16 and HPV-18 L1 Virus-like Particles as Defined by Monoclonal Antibodies

1996 • 251 citations

Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18

2005 • 245 citations

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

1995 • 167 citations

Immunological analyses of human papillomavirus capsids

2001 • 152 citations

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies

1994 • 151 citations

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1994 • 149 citations

Human Papillomavirus Type 11 (HPV‐11) Neutralizing Antibodies in the Serum and Genital Mucosal Secretions of African Green Monkeys Immunized with HPV‐11 Virus‐like Particles Expressed in Yeast

1997 • 134 citations

Sequence Determination of Human Papillomavirus Type 6a and Assembly of Virus-like Particles in Saccharomyces cerevisiae

1995 • 133 citations

Human Papillomavirus Types 6 and 11 Have Antigenically Distinct Strongly Immunogenic Conformationally Dependent Neutralizing Epitopes

1994 • 131 citations

In Vitro Infection and Type-Restricted Antibody-Mediated Neutralization of Authentic Human Papillomavirus Type 16

1998 • 130 citations

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

1990 • 120 citations

Human papillomavirus vaccines

2006 • 104 citations

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

2004 • 94 citations

Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma

1996 • 93 citations

Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus‐like particles in colombian women with invasive cervical cancer

2001 • 78 citations

Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae

1996 • 46 citations

Cited By (0)

No citing papers found in database